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Pulmonary transplantation (LTx)  is a viable treatment 
option for patients with final stage lung disease such as 
cystic fibrosis (CF), chronic obstructive pulmonary disease 
(COPD) and interstitial lung disease (1,2). Advances in 
surgical techniques, pre- and post-operative management 
have improved overall survival of lung-transplanted patients 
over the past decades. Despite these developments, lung 
transplantation has still significantly higher morbidity and 
mortality than transplants of other solid organs such as 
kidney and liver. For these reasons, several studies have 
been conducted to investigate factors that potentially affect 
the prognosis of patients who undergo LTx (3).
Nutritional assessment plays a crucial role in recipient 
evaluation. Heterogeneous clinical features characterize 
LTx candidates from a nutritional point of view. In most 
cases, young patients with CF have pancreatic insufficiency 
leading to malabsorption and extreme thinness; on the 
contrary, patients with pulmonary fibrosis are older, with 
long smoking history and usually they are overweight 
or obese. This heterogeneity, as well as comorbidities, 
influence nutritional requirements and outcome of LTx 
patients. 
In this context, we read with great interest the article 
by Lu et al. (4) “Can the preoperative nutritional risk score 
be a predictor of outcomes in critically ill patients of lung 
transplantation: a retrospective study”. The authors performed 
a single center, retrospective observational cohort study of 
42 patients who underwent LTx and evaluated the role of 
nutritional assessment. Indices applied to characterize the 
nutritional status were nutritional risk screening (NRS-
2002) and prognostic nutritional index (PNI) (5). The 
Authors concluded that PNI and NRS2002 were not 
independent predictors for post-operative mortality; on 
the contrary, ECMO assistance was the only independent 
predictor for increased mortality in their cohort.
Lung transplant’s literature is rather conflicting on this 
topic. In a meta-analysis including seven papers, Upala and 
coauthors found a significant risk of mortality after LTx in 
candidates with underweight and obesity (6). This meta-
analysis also denied any significant risk of primary graft 
dysfunction in obese and overweight candidates. On the 
other hand, Singer and coauthors came to more articulated 
conclusions. Using multivariable-adjusted regression 
models in 9,073 patients who underwent LTx in the United 
States, Singer found that a body mass index (BMI) of 30– 
34 kg/m2 was not associated with 1-year mortality, but BMI 
>35 was related with a large increase in mortality (7). In 
the same paper, Singer reported a multicenter prospective 
cohort study aimed to correlate plasma leptin and mortality 
in 599 LTx patients. This second part of the paper found 
a doubtful correlation between high preoperative leptin 
level and 1-year mortality rates among patients who did not 
required cardiopulmonary by-pass during surgery. Singer 
speculated that higher preoperative plasma leptin levels 
was a better marker of increased adiposity than BMI and 
consequently leptin could better correlate with increased 
1-year mortality after LTx.
Actually, obesity is a state of positive energy balance 
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characterized by low-grade inflammation and weakened 
innate and adaptive immune responses; adipose tissue 
produces free fatty acid and activates pro-inflammatory 
serine kinase cascades (8). In a recent meta-analysis, the 
authors observed that the correlation between leptin and 
inflammatory biomarkers was stronger in young individuals 
but decreased with age (9). The age-dependent change 
in body fat distribution led the authors to attribute that 
finding to the shift of fat accumulation from subcutaneous 
to visceral areas. Conversely, this meta-analysis found 
an inverse correlation between adiponectin (an adipose 
tissue‐derived hormone) and biomarkers of immunity and 
inflammation (C-reactive protein, interleukin-6, and tumor 
necrosis factor-α). Actually, additional studies are necessary 
to better understand the complex role of “adiposity” in LTx. 
CF deserves some special considerations. There is a 
known association between the CF and malnutrition, 
which is partly the result of a combination of lower 
energy intake, higher turnover of essential fatty acids and 
higher energy consumption due to frequent pulmonary 
infections. In addition, patients with CF suffer from 
pancreatic insufficiency and CF-related diabetes that causes 
malabsorption (10). Recently, Ashkenazi and colleagues 
conducted a retrospective study that included patients 
with CF treated at the Sheba Medical Center and followed 
up for 10 years (11). The authors found a statistically 
significant correlation between BMI at the age of 10 and 
FEV1 at the age of 20 years; in additions, the multivariate 
analysis indicated low BMI as a determinant for future lung 
transplantation. A little retrospective study conducted in the 
same institution concluded that improvement in BMI could 
have a positive influence on patient’s survival after LTx (12). 
Recently, researchers from Vienna published a prospective 
study on 58 CF patients who received LTx; this study found 
that more than one-quarter of the cohort had a BMI < 
18.5 kg/m2 (13). Malnourished patients had lower 
pulmonary function versus normal or overweight 
individuals. In addition, the pulmonary function decreased 
over time in patient with low BMI. 
The Lu’s paper prompted as to review our cohort of 
patients who received lung transplantation from 2011 
to 2018. Our cohort included 193 patients, mean age: 
43 years, male: 103 (53%), CF patients: 98 (51%), mean 
BMI 22.2, single LTx: 39 (20%), Lung Allocation Score: 
47.4, ex vivo lung perfusion: 33 (17%), intraoperative 
ECMO: 82 (42.5%). We performed a Cox regression 
model to analyze the impact of major clinical characteristics 
on survival; the following variables resulted statistically 
significant: BMI [hazard ratio (HR): 1.055; 95% CI: 1.003 
to 1.110; P: 0.038], age (HR: 1.024; 95% CI: 1.007 to 
1.040; P: 0.005), CF (HR: 0.429; 95% CI: 0.264 to 0.698; 
P<0.001), single LTx (HR: 2.302; 95% CI: 1.432 to 3.702; 
P<0.001). Including these variables in a stepwise Cox 
model, only CF diagnosis remained significant showing a 
“protective effect” on survival (HR: 0.536, 95% CI: 0.305 
to 0.940; P: 0.029). Finally, we categorized patients in three 
BMI classes: <18.6; 18.6 to 29.9; >29.9. The Kaplan-Meier 
curves are reported in Figure 1; there was not statistically 
significant difference among groups. Despite higher BMI 
seems negatively affect the survival when it is considered 
alone, our data suggest that the complexity of covariates 
concurring to determine the survival make the judgment on 
overweight rather difficult.
In conclusion, the paper by the Wuxi researchers raised 
attention to the problem of weight disorders in lung 
recipients but much remains to be studied to correctly 
understand the real impact of this important feature on 
survival.
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Figure 1 Kaplan-Meier curve for lung transplantation and survival 
by BMI class. BMI, body mass index.
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to the accuracy or integrity of any part of the work are 
appropriately investigated and resolved.
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